With its moat, wall, barbed wire, armed guards and security cameras, the facility could be mistaken for a military base were it not for the pungent odor of marijuana in the air.
On the outskirts of a quiet village in northern Israel, 50,000 plants of 230 varieties grow at the country’s second-largest medical cannabis plantation.
“For cannabis, we are in the promised land, with a good climate, 300 days of sunshine each year and perfect levels of humidity,” said Tamir Gedo, CEO of BOL Pharma, a company authorized by the Israeli Ministry of Health to grow and distribute medical cannabis.
The recreational use of cannabis is illegal in the Jewish state, but for the past 10 years its therapeutic use has not only been permitted, but also encouraged.
Last year, doctors prescribed the herb to about 25,000 patients suffering from cancer, epilepsy, post-traumatic stress and degenerative diseases.
The purpose is not to cure them, but to alleviate their symptoms.
The use of cannabis in medicine divides doctors around issues of addiction and behavioral problems such as aggression.
Nevertheless, it has long been known to revive lost appetite and to help in treating sleep disorders, anxiety and inflammation, its supporters say.
They say much research remains to be done, but it is advancing faster in Israel, where authorities allow human clinical trials, than in many other countries.
Entrepreneurs, investors and researchers are increasingly entering the business and searching for the holy grail of medicinal marijuana: a purified form of the drug with minimal side-effects, which can be administered in accurate doses.
Inside the fortified premises of BOL (Breath Of Life) Pharma are laboratories and greenhouses, with each plant monitored by software that remotely controls its biochemical parameters.
Growing cannabis for medical use demands careful supervision of active ingredients such as tetrahydrocannabinol, which gives recreational users their high, but is not recommended for all patients, particularly children.
“With the support of the [health] ministry, which has always had a pioneering attitude to this issue, we have built up expertise in clinical trials and we can share it with companies in the United States and Europe,” Gedo said.
He cites initial results of trials on patients with Crohn’s disease, which is characterized by chronic inflammation of the intestine, diarrhea and recurrent abdominal pain.
Forbidden to export its cannabis plants, Israel is concentrating instead on marketing its agronomic, medical and technological expertise in the hope of becoming a world hub in the field.
The prestigious Hebrew University of Jerusalem has just opened a cannabis research center joining 19 other teams from local academic institutions.
About 200 industry players gathered in Tel Aviv this month for Canna Tech, an international conference on the industry.
Suited salespeople, some a little red-eyed, despite a ban on consumption laid down by the organizers, exhibited products including electronic cannabis cigarettes, cannabis-based creams and ointments and a remedy for dry mouth.
Some start-ups have been focused on the plant’s by-products, others on user accessories, but a few have bigger ideas.
“Look at what has happened in the past two years, the speed at which legalization of cannabis is advancing,” said Saul Kaye, head of the first Israeli incubator for cannabis industry start-ups.
“We’re not going to miss this opportunity, and seeing what the first investors are putting on the table, we feel that it is going to be very big,” Kaye added.
In January, US tobacco giant Philip Morris plowed US$20 million into Israeli company Syke, which produces precision inhalers for medical cannabis.
At the same time, Israeli firm Eybna announced it had isolated therapeutic organic compounds from the plant without the psychoactive ingredients that make unprescribed use illegal.
RIGHTS FEARS: A protester said Beijing would use the embassy to catch and send Hong Kongers to China, while a lawmaker said Chinese agents had threatened Britons Hundreds of demonstrators on Saturday protested at a site earmarked for Beijing’s controversial new embassy in London over human rights and security concerns. The new embassy — if approved by the British government — would be the “biggest Chinese embassy in Europe,” one lawmaker said earlier. Protester Iona Boswell, a 40-year-old social worker, said there was “no need for a mega embassy here” and that she believed it would be used to facilitate the “harassment of dissidents.” China has for several years been trying to relocate its embassy, currently in the British capital’s upmarket Marylebone district, to the sprawling historic site in the
A deluge of disinformation about a virus called hMPV is stoking anti-China sentiment across Asia and spurring unfounded concerns of renewed lockdowns, despite experts dismissing comparisons with the COVID-19 pandemic five years ago. Agence France-Presse’s fact-checkers have debunked a slew of social media posts about the usually non-fatal respiratory disease human metapneumovirus after cases rose in China. Many of these posts claimed that people were dying and that a national emergency had been declared. Garnering tens of thousands of views, some posts recycled old footage from China’s draconian lockdowns during the COVID-19 pandemic, which originated in the country in late
French police on Monday arrested a man in his 20s on suspicion of murder after an 11-year-old girl was found dead in a wood south of Paris over the weekend in a killing that sparked shock and a massive search for clues. The girl, named as Louise, was found stabbed to death in the Essonne region south of Paris in the night of Friday to Saturday, police said. She had been missing since leaving school on Friday afternoon and was found just a few hundred meters from her school. A police source, who asked not to be named, said that she had been
BACK TO BATTLE: North Korean soldiers have returned to the front lines in Russia’s Kursk region after earlier reports that Moscow had withdrawn them following heavy losses Ukrainian President Volodymyr Zelenskiy on Friday pored over a once-classified map of vast deposits of rare earths and other critical minerals as part of a push to appeal to US President Donald Trump’s penchant for a deal. The US president, whose administration is pressing for a rapid end to Ukraine’s war with Russia, on Monday said he wanted Ukraine to supply the US with rare earths and other minerals in return for financially supporting its war effort. “If we are talking about a deal, then let’s do a deal, we are only for it,” Zelenskiy said, emphasizing Ukraine’s need for security guarantees